COLL vs TDG · P/E 17, rev $181.9M vs P/E 41, rev $8.83B
Collegium Pharmaceutical Inc (COLL) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. Revenue was up 11.2% from 2024-09-30 to 2025-09-30. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the COLL and TDG stock pages for the full models.
Not investment advice.